Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT03708432
Brief Summary:
To study the real world use of 500mg Fulvestrant in HR+ MBC.
Detailed Description:
An observational, retrospective study of 500mg Fulvestrant in hormone receptor+/HER2- advanced breast cancer
Study:
NCT03708432
Study Brief:
Protocol Section:
NCT03708432